# Episode #45: From Big Pharma to Microbiome Innovation with Bindu Shah from Biocodex

Page: https://stenobird.com/podcast/from-lab-to-label-the-scientification-of-consumer-brands-6420614/episode-45-from-big-pharma-to-microbiome-innovation-with-bindu-shah-from-biocodex
Text version: https://stenobird.com/podcast/from-lab-to-label-the-scientification-of-consumer-brands-6420614/episode-45-from-big-pharma-to-microbiome-innovation-with-bindu-shah-from-biocodex.md
Podcast: [From Lab to Label: The Scientification of Consumer Brands](https://stenobird.com/podcast/from-lab-to-label-the-scientification-of-consumer-brands-6420614)
Published: 2026-02-11T10:31:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/citruslabs/episodes/Episode-45-From-Big-Pharma-to-Microbiome-Innovation-with-Bindu-Shah-from-Biocodex-e3eodfe
Audio file: https://anchor.fm/s/de83c94c/podcast/play/115143598/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-6%2F417620782-44100-2-a43d2723f270a.m4a
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/from-lab-to-label-the-scientification-of-consumer-brands-6420614/episodes/episode-45-from-big-pharma-to-microbiome-innovation-with-bindu-shah-from-biocodex
Duration seconds: 2707

## Resource

In this episode, Susanne sits down with Bindu Shah, Chief Marketing Officer at Biocodex, to talk about what it takes to grow a science-first probiotic brand. Drawing on her experience across Johnson & Johnson, Pfizer, GSK, and Haleon, Bindu shares what shifted when she moved from global consumer giants to a family-owned French pharmaceutical company, and how that change has shaped Biocodex’s next chapter. What’s covered in this episode: Bindu’s journey through iconic consumer health brands and what those experiences taught her about building trust. What really changes when you move from a public company environment to a family-owned, science-led business. How Biocodex is refreshing Florastor and expanding beyond traditional probiotic use cases. The growing gut-vaginal connection and what it means for the future of women’s microbiome care. New microbiome areas to watch, from oral health and satiety to gut-mood support. Bindu’s personal wellness routine, including the supplements and habits she relies on daily. Tune in to hear how Biocodex is translating microbiome science into real-world benefits, and why the next wave of women’s health innovation is just getting started! About Biocodex Biocodex is an international pharmaceutical company founded in 1953, with a mission to improve the health and well-being of women, men, and children worldwide. The company focuses on three core areas of expertise: microbiota care, women’s health, and orphan diseases. As a pioneer in probiotics and intimate health solutions, Biocodex is committed to delivering innovative products while advancing scientific research for the benefit of patients everywhere. Guided by a responsible and sustainable approach, their teams work closely with healthcare professionals and partners to meet evolvi…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/from-lab-to-label-the-scientification-of-consumer-brands-6420614/episodes/episode-45-from-big-pharma-to-microbiome-innovation-with-bindu-shah-from-biocodex/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/from-lab-to-label-the-scientification-of-consumer-brands-6420614/episode-45-from-big-pharma-to-microbiome-innovation-with-bindu-shah-from-biocodex.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.